QA: Chinook Therapeutics INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001435049_2021_Chinook_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001435049, Chinook Therapeutics INC

  xvar xval
0 AssetsCurrent 254,081,000
1 IntangibleAssetsNetIncludingGoodwill 50,137,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 124,784,000
4 LiabilitiesCurrent 22,809,000
5 LiabilitiesNoncurrent 39,614,000
6 remainder_Liabilities 31,957,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,281,943
9 ResearchAndDevelopmentExpense 9,537,090
10 remainder_Expenses 22,894,534
11 remainder_Revenues 2,617,292
12 remainder_NetIncome -4,387,887
13 remainder_ComprehensiveNetIncome -209,721
  yvar yval
0 Assets 429,002,000
1 Liabilities 94,380,000
2 Expenses 46,713,567
3 Revenues 2,617,292
4 StockholdersEquity 334,622,000
5 NetIncome -48,484,162
6 ComprehensiveNetIncome -48,589,022
7 BaseVar 288,655,234
8 EconomicCapitalRatiobeforeLimitedLiability 2.60
9 EconomicCapitalRatio 3.42

Edgar->Model Mapping

Feature Distribution

Change over Time